Comparison of spantide II and CP-96,345 for blockade of tachykinin-evoked contractions of smooth muscle.

[1]  J. Howbert,et al.  Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P. , 1991, Biochemical and biophysical research communications.

[2]  I. Morton,et al.  Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea‐pig vas deferens , 1991, British journal of pharmacology.

[3]  A. Ganong,et al.  Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist. , 1991, Science.

[4]  J. Lowe,et al.  A potent nonpeptide antagonist of the substance P (NK1) receptor. , 1991, Science.

[5]  R. Håkanson,et al.  Spantide II, a novel tachykinin antagonist having high potency and low histamine-releasing effect , 1990, Regulatory Peptides.

[6]  C. Maggi,et al.  Competitive antagonists discriminate between NK2 tachykinin receptor subtypes , 1990, British journal of pharmacology.

[7]  R. Håkanson,et al.  Increased potency of antagonists of substance P having asparagine in position 6 , 1989, Regulatory Peptides.

[8]  D. Regoli,et al.  Receptors for substance P and related neurokinins. , 1989, Pharmacology.

[9]  P. Holzer,et al.  Local effector functions of capsaicin-sensitive sensory nerve endings: Involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides , 1988, Neuroscience.

[10]  R. Håkanson,et al.  Biological evaluation of substance P antagonists , 1984, British journal of pharmacology.

[11]  E. Escher,et al.  Substance P--structure-activity studies and the development of antagonists. , 1984, Pharmacology.

[12]  K. Folkers,et al.  Substance P- antagonists: a new type of pharmacological tool , 1982 .